Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Bladder Cancer

Free Subscription 02.08.2021 1 A A Pract 1 Acta Biochim Pol 2 Aging (Albany NY) 1 Agri 1 Am J Clin Exp Urol 1 An Bras Dermatol 1 Anticancer Agents Med Chem 1 Anticancer Res 1 BMC Cancer 1 Cancer Cell Int 3 Cancer Cytopathol 1 Cancer Nurs 1 Clin Transl Med 1 Curr Probl Cancer 2 Front Cell Dev Biol 3 Front Oncol 1 Front Pharmacol 2 Indian J Pathol Microbiol 1 Indian J Surg Oncol 1 Int J Biol Sci 1 Int J Clin Oncol 1 Int J Clin Pract 1 Int J Mol Sci 1 Int J Radiat Oncol Biol Phys 1 Int J Urol 1 J Biochem Mol Toxicol 1 J Carcinog 1 J Geriatr Oncol 1 J Investig Med High Impact Case Rep 1 J Oncol 1 J Smok Cessat 1 Mamm Genome 1 Minerva Urol Nephrol 2 Nan Fang Yi Ke Da Xue Xue Bao 1 Oncoimmunology 1 Sci Rep 4 Transl Androl Urol 1 Urol Oncol 2 Urologe A 1 World J Surg Oncol 1 Yonsei Med J 1 Zhonghua Zhong Liu Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

A A Pract

1. PATEL SY, Kubal TE, Li R, Manley BJ, et al
   Prevalence of Preoperative Iron Deficiency Anemia: A Case Series Among Patients Undergoing Radical Cystectomy.
   A A Pract. 2021;15:e01477.
   PubMed         Abstract available
   
   

   
   Acta Biochim Pol

2. WISNIOWSKI T, Bryda J, Kurzepa J, Watroba S, et al
   The role of matrix metalloproteinases in pathogenesis of human bladder cancer.
   Acta Biochim Pol. 2021 Jul 27. pii: 5600. doi: 10.18388/abp.2020_5600.
   PubMed         Abstract available
   
   

   
   Aging (Albany NY)

3. GUO L, Wu Q, Ma Z, Yuan M, et al
   Identification of immune-related genes that predict prognosis and risk of bladder cancer: bioinformatics analysis of TCGA database.
   Aging (Albany NY). 2021;13.
   PubMed         Abstract available
   
   
4. MAO X, Chen S, Li G
   Identification of a ten-long noncoding RNA signature for predicting the survival and immune status of patients with bladder urothelial carcinoma based on the GEO database: a superior machine learning model.
   Aging (Albany NY). 2021;13:6957-6981.
   PubMed         Abstract available
   
   

   
   Agri

5. SEN S, Tuncyurek O, Ertekin E, Dundar M, et al
   The Effect of Spinal and General Anesthesia on Metastatic Lymph Node Flow in Bladder Cancer Surgery: A Pilot Study.
   Agri. 2021;33:142-147.
   PubMed         Abstract available
   
   

   
   Am J Clin Exp Urol

6. NGUYEN TP, Zhang CA, Sonn GA, Eisenberg ML, et al
   Consumption of cruciferous vegetables and the risk of bladder cancer in a prospective US cohort: data from the NIH-AARP diet and health study.
   Am J Clin Exp Urol. 2021;9:229-238.
   PubMed         Abstract available
   
   

   
   An Bras Dermatol

7. GOMEZ-MOYANO E, Martinez Garcia S, Hernandez Alcaraz D, Ayala-Blanca M, et al
   Metastatic urothelial carcinoma.
   An Bras Dermatol. 2021;96:519-520.
   PubMed        
   
   

   
   Anticancer Agents Med Chem

8. AMINZADEH Z, Ziamajidi N, Abbasalipourkabir R
   Anticancer Effects of Cinnamaldehyde through Inhibition of ErbB2/HSF1/LDHA Pathway in 5637 Cell Line of Bladder Cancer.
   Anticancer Agents Med Chem. 2021 Jul 26. pii: ACAMC-EPUB-116852.
   PubMed         Abstract available
   
   

   
   Anticancer Res

9. MATSUNAGA W, Hamada K, Tagawa M, Morinaga T, et al
   Cancer Cell-specific Transfection of hCas9 Gene Using Ad5F35 Vector.
   Anticancer Res. 2021;41:3731-3740.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. LI J, Cao J, Li P, Yao Z, et al
    Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    BMC Cancer. 2021;21:858.
    PubMed         Abstract available
    
    

    
    Cancer Cell Int

11. LUO Y, Zhou J, Tang J, Zhou F, et al
    MINDY1 promotes bladder cancer progression by stabilizing YAP.
    Cancer Cell Int. 2021;21:395.
    PubMed         Abstract available
    
    

    
    Cancer Cytopathol

12. NGUYEN L, Nilforoushan N, Krane JF, Bose S, et al
    Should "suspicious for high-grade urothelial carcinoma" and "positive for high-grade urothelial carcinoma" remain separate categories?
    Cancer Cytopathol. 2021;129:156-163.
    PubMed         Abstract available
    
    
13. TIAN W, Shore KT, Shah RB
    Significant reduction of indeterminate (atypical) diagnosis after implementation of The Paris System for Reporting Urinary Cytology: A single-institution study of more than 27,000 cases.
    Cancer Cytopathol. 2021;129:114-120.
    PubMed         Abstract available
    
    
14. ZHANG ML, Miki Y, Hang JF, Vohra M, et al
    A review of upper urinary tract cytology performance before and after the implementation of The Paris System.
    Cancer Cytopathol. 2021;129:264-274.
    PubMed         Abstract available
    
    

    
    Cancer Nurs

15. YI E, Yoo YS, Lee S, Park H, et al
    The Experiences of Illness in Korean Bladder Cancer Patients With Radical Cystectomy.
    Cancer Nurs. 2021 Jul 21. pii: 00002820-900000000-98828.
    PubMed         Abstract available
    
    

    
    Clin Transl Med

16. ZHENG H, Chen C, Luo Y, Yu M, et al
    Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer.
    Clin Transl Med. 2021;11:e497.
    PubMed         Abstract available
    
    

    
    Curr Probl Cancer

17. PETZOLD AP, Lubianca FN, Passos LG, Keppler CK, et al
    The impact of preoperative immune checkpoint inhibitors on kidney and bladder cancer surgeries: a systematic review().
    Curr Probl Cancer. 2021 Jul 8:100765. doi: 10.1016/j.currproblcancer.2021.100765
    PubMed         Abstract available
    
    

    
    Front Cell Dev Biol

18. ZOU J, Huang R, Chen Y, Huang X, et al
    Dihydropyrimidinase Like 2 Promotes Bladder Cancer Progression via Pyruvate Kinase M2-Induced Aerobic Glycolysis and Epithelial-Mesenchymal Transition.
    Front Cell Dev Biol. 2021;9:641432.
    PubMed         Abstract available
    
    
19. YANG C, Wu S, Mou Z, Zhou Q, et al
    Transcriptomic Analysis Identified ARHGAP Family as a Novel Biomarker Associated With Tumor-Promoting Immune Infiltration and Nanomechanical Characteristics in Bladder Cancer.
    Front Cell Dev Biol. 2021;9:657219.
    PubMed         Abstract available
    
    

    
    Front Oncol

20. LI H, Cao Y, Ma P, Ma Z, et al
    Novel Visualization Methods Assisted Transurethral Resection for Bladder Cancer: An Updated Survival-Based Systematic Review and Meta-Analysis.
    Front Oncol. 2021;11:644341.
    PubMed         Abstract available
    
    
21. ZHANG X, Li X, Fu X, Yu M, et al
    Circular RNA TAF4B Promotes Bladder Cancer Progression by Sponging miR-1298-5p and Regulating TGFA Expression.
    Front Oncol. 2021;11:643362.
    PubMed         Abstract available
    
    
22. HUA S, Xie Z, Wang W, Wan Z, et al
    Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer.
    Front Oncol. 2021;11:704946.
    PubMed         Abstract available
    
    

    
    Front Pharmacol

23. LU H, Mei C, Yang L, Zheng J, et al
    PPM-18, an Analog of Vitamin K, Induces Autophagy and Apoptosis in Bladder Cancer Cells Through ROS and AMPK Signaling Pathways.
    Front Pharmacol. 2021;12:684915.
    PubMed         Abstract available
    
    

    
    Indian J Pathol Microbiol

24. KARAKAYA YA, Oral E
    Correlation of cyclin D1, HER2, and AMACR expressions with histologic grade in bladder urothelial carcinomas.
    Indian J Pathol Microbiol. 2021;64:84-90.
    PubMed         Abstract available
    
    
25. NAMBIYAR K, Mitra S, Das A, Bal A, et al
    Adenocarcinoma of the colon and urinary bladder: A fortuitous or an embryological phenomenon?
    Indian J Pathol Microbiol. 2021;64:132-135.
    PubMed         Abstract available
    
    

    
    Indian J Surg Oncol

26. SHADAB R, Nerli RB, Saziya BR, Ghagane SC, et al
    5-ALA-Induced Fluorescent Cytology in the Diagnosis of Bladder Cancer-a Preliminary Report.
    Indian J Surg Oncol. 2021;12:415-420.
    PubMed         Abstract available
    
    

    
    Int J Biol Sci

27. HE H, Yi L, Zhang B, Yan B, et al
    USP24-GSDMB complex promotes bladder cancer proliferation via activation of the STAT3 pathway.
    Int J Biol Sci. 2021;17:2417-2429.
    PubMed         Abstract available
    
    

    
    Int J Clin Oncol

28. IIDA K, Miyake M, Murakami K, Komiyama M, et al
    Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy.
    Int J Clin Oncol. 2021 Jul 27. pii: 10.1007/s10147-021-01988.
    PubMed         Abstract available
    
    

    
    Int J Clin Pract

29. YITGIN Y, Erdem S, Serilmez M, Duranyildiz D, et al
    Can serum matrix metalloproteinase-9 and SMAD-2 levels predict lamina propria invasion in bladder urothelial carcinoma?
    Int J Clin Pract. 2021;75:e14277.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

30. GIL-JULIO H, Perea F, Rodriguez-Nicolas A, Cozar JM, et al
    Tumor Escape Phenotype in Bladder Cancer Is Associated with Loss of HLA Class I Expression, T-Cell Exclusion and Stromal Changes.
    Int J Mol Sci. 2021;22.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

31. CHIN S, Song YP
    Double Trouble.
    Int J Radiat Oncol Biol Phys. 2021;109:844-845.
    PubMed        
    
    

    
    Int J Urol

32. SHIN T, Mimata H
    "Early-pull-out" technique for intracorporeal ileal conduit urinary diversion after robot-assisted radical cystectomy.
    Int J Urol. 2021;28:778-779.
    PubMed        
    
    

    
    J Biochem Mol Toxicol

33. YU X, Liao B, Zhu P, Cheng S, et al
    beta-Caryophyllene induces apoptosis and inhibits cell proliferation by deregulation of STAT-3/mTOR/AKT signaling in human bladder cancer cells: An in vitro study.
    J Biochem Mol Toxicol. 2021 Jul 28:e22863. doi: 10.1002/jbt.22863.
    PubMed         Abstract available
    
    

    
    J Carcinog

34. GUPTA A, Gupta S, Siddeek RAT, Chennatt JJ, et al
    Demographic and clinicopathological Profile of Gall Bladder Cancer Patients: Study from a tertiary care center of the Sub-Himalayan region in Indo-Gangetic Belt.
    J Carcinog. 2021;20:6.
    PubMed         Abstract available
    
    

    
    J Geriatr Oncol

35. DINAN MA, Georgieva MV, Li Y, Zhang T, et al
    Real-world systemic therapy utilization in Medicare patients with locally advanced or metastatic urothelial carcinoma diagnosed between 2008 and 2012.
    J Geriatr Oncol. 2021;12:298-304.
    PubMed         Abstract available
    
    

    
    J Investig Med High Impact Case Rep

36. SINGH B, Kaur P, Gupta S, Guragai N, et al
    Complete Response With Immunotherapy: A Case of Metastatic Bladder Cancer.
    J Investig Med High Impact Case Rep. 2021;9:23247096211035603.
    PubMed         Abstract available
    
    

    
    J Oncol

37. GAO D, Niu Q, Gong Y, Guo Q, et al
    Y-Box Binding Protein 1 Regulates Angiogenesis in Bladder Cancer via miR-29b-3p-VEGFA Pathway.
    J Oncol. 2021;2021:9913015.
    PubMed         Abstract available
    
    

    
    J Smok Cessat

38. JABRA E, Al-Omari A, Haddadin F, Alam W, et al
    Waterpipe Smoking among Bladder Cancer Patients: A Cross-Sectional Study of Lebanese and Jordanian Populations.
    J Smok Cessat. 2021;2021:6615832.
    PubMed         Abstract available
    
    

    
    Mamm Genome

39. MEI Y, Wu Y, Ma L, Zhang H, et al
    Overexpression of ROCK1 promotes cancer cell proliferation and is associated with poor prognosis in human urothelial bladder cancer.
    Mamm Genome. 2021 Jul 28. pii: 10.1007/s00335-021-09896.
    PubMed         Abstract available
    
    

    
    Minerva Urol Nephrol

40. ALBISINNI S, Martinez Chanza N, Aoun F, Diamand R, et al
    Immune checkpoint inhibitors for BCG-resistant NMIBC: the dawn of a new era.
    Minerva Urol Nephrol. 2021;73:292-298.
    PubMed         Abstract available
    
    

    
    Nan Fang Yi Ke Da Xue Xue Bao

41. ZHI X, Zhou J, Tian H, Zhou R, et al
    [SHOX2 promotes migration, invasion and stemness of bladder cancer cells in vitro].
    Nan Fang Yi Ke Da Xue Xue Bao. 2021;41:995-1001.
    PubMed         Abstract available
    
    
42. YAO Y, Zhang C, Xiong Y, Han B, et al
    [miR-let-7c-5p inhibits invasion and migration of bladder cancer cells by targeting HMGA2].
    Nan Fang Yi Ke Da Xue Xue Bao. 2021;41:1022-1029.
    PubMed         Abstract available
    
    

    
    Oncoimmunology

43. CHENG S, Zhong W, Xia K, Hong P, et al
    Prognostic role of stromal tumor-infiltrating lymphocytes in locally advanced upper tract urothelial carcinoma: A retrospective multicenter study (TSU-02 study).
    Oncoimmunology. 2021;10:1861737.
    PubMed         Abstract available
    
    

    
    Sci Rep

44. WIGNER P, Szymanska B, Bijak M, Sawicka E, et al
    Oxidative stress parameters as biomarkers of bladder cancer development and progression.
    Sci Rep. 2021;11:15134.
    PubMed         Abstract available
    
    

    
    Transl Androl Urol

45. PAN JW, Zhang X, Jin XW, Wang XJ, et al
    Hydropenia may accelerates the progression of orthotopic bladder cancer induced by N-methyl-N-nitrosourea by increasing the expression levels of AQP1, AQP3, and AQP4.
    Transl Androl Urol. 2021;10:2447-2453.
    PubMed         Abstract available
    
    
46. RUSSELL B, Kotecha P, Thurairaja R, Nair R, et al
    Endoscopic surveillance for bladder cancer: a systematic review of contemporary worldwide practices.
    Transl Androl Urol. 2021;10:2750-2761.
    PubMed         Abstract available
    
    
47. NAYAK A, Cresswell J, Mariappan P
    Quality of life in patients undergoing surveillance for non-muscle invasive bladder cancer-a systematic review.
    Transl Androl Urol. 2021;10:2737-2749.
    PubMed         Abstract available
    
    
48. HUMAYUN-ZAKARIA N, Ward DG, Arnold R, Bryan RT, et al
    Trends in urine biomarker discovery for urothelial bladder cancer: DNA, RNA, or protein?
    Transl Androl Urol. 2021;10:2787-2808.
    PubMed         Abstract available
    
    

    
    Urol Oncol

49. HINSENVELD FJ, Boormans JL, van der Poel HG, van der Schoot DKE, et al
    Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands.
    Urol Oncol. 2021 Jul 21. pii: S1078-1439(21)00277.
    PubMed         Abstract available
    
    

    
    Urologe A

50. OTTO W, Wieland WF
    [Interactions between radical prostatovesiculectomy and diagnosis of prostate cancer : A medical-historical inventory on the occasion of 20 years of robot-assisted treatment].
    Urologe A. 2021;60:1039-1050.
    PubMed         Abstract available
    
    
51. GOLKA K, Bothig R, Jungmann O, Forchert M, et al
    [Occupational cancers in urology].
    Urologe A. 2021;60:1061-1072.
    PubMed         Abstract available
    
    

    
    World J Surg Oncol

52. HE H, Liu T, Han D, Li C, et al
    Incidence trends and survival prediction of urothelial cancer of the bladder: a population-based study.
    World J Surg Oncol. 2021;19:221.
    PubMed         Abstract available
    
    

    
    Yonsei Med J

53. LEE TH, Heo JH, Jeong JY, Lee GH, et al
    Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion.
    Yonsei Med J. 2021;62:679-690.
    PubMed         Abstract available
    
    

    
    Zhonghua Zhong Liu Za Zhi

54. WANG C, Sun ZQ, Liu MY, Zhang JJ, et al
    [Prognostic analysis of patients with T1 stage high grade of bladder urothelial carcinoma and glandular differentiation].
    Zhonghua Zhong Liu Za Zhi. 2021;43:691-695.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: